BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger Agreement

Reuters

Yesterday

BRIEF-Rallybio Corporation And Candid <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announce Merger Agreement

March 2 (Reuters) - Rallybio Corp RLYB.O:

RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENT
RALLYBIO CORP - OVER $505 MILLION FINANCING COMMITTED BY INVESTORS
RALLYBIO CORP: COMBINED COMPANY'S CASH BALANCE AT CLOSING IS EXPECTED TO FUND OPERATIONS THROUGH 2030
RALLYBIO CORP: PRE-TRANSACTION RALLYBIO EQUITYHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 3.65% OF COMBINED CO
RALLYBIO CORP - KEN SONG TO LEAD COMBINED COMPANY AS CEO
RALLYBIO CORP - PRO-FORMA CASH OF ABOUT $700 MILLION EXPECTED AT CLOSING

Source text: ID:nBw1f6M4wa

Further company coverage: RLYB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2616033717"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616033717\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616033717?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-02 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616033717","market":"nz","top_or_hot":-1,"title":"BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Rallybio Corporation And Candid <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announce Merger Agreement</title></head><body><p><span>March 2 (Reuters)</span><span> - </span>Rallybio Corp <span>RLYB.O</span>:</p><ul><li><p>RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENT</p></li><li><p>RALLYBIO CORP - OVER $505 MILLION FINANCING COMMITTED BY INVESTORS</p></li><li><p>RALLYBIO CORP: COMBINED COMPANY'S CASH BALANCE AT CLOSING IS EXPECTED TO FUND OPERATIONS THROUGH 2030</p></li><li><p>RALLYBIO CORP: PRE-TRANSACTION RALLYBIO EQUITYHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 3.65% OF COMBINED CO</p></li><li><p>RALLYBIO CORP - KEN SONG TO LEAD COMBINED COMPANY AS CEO</p></li><li><p>RALLYBIO CORP - PRO-FORMA CASH OF ABOUT $700 MILLION EXPECTED AT CLOSING</p></li></ul><p>Source text: <span>ID:nBw1f6M4wa</span></p><p>Further company coverage: <span>RLYB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-02 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Rallybio Corporation And Candid <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Announce Merger Agreement</title></head><body><p><span>March 2 (Reuters)</span><span> - </span>Rallybio Corp <span>RLYB.O</span>:</p><ul><li><p>RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENT</p></li><li><p>RALLYBIO CORP - OVER $505 MILLION FINANCING COMMITTED BY INVESTORS</p></li><li><p>RALLYBIO CORP: COMBINED COMPANY'S CASH BALANCE AT CLOSING IS EXPECTED TO FUND OPERATIONS THROUGH 2030</p></li><li><p>RALLYBIO CORP: PRE-TRANSACTION RALLYBIO EQUITYHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 3.65% OF COMBINED CO</p></li><li><p>RALLYBIO CORP - KEN SONG TO LEAD COMBINED COMPANY AS CEO</p></li><li><p>RALLYBIO CORP - PRO-FORMA CASH OF ABOUT $700 MILLION EXPECTED AT CLOSING</p></li></ul><p>Source text: <span>ID:nBw1f6M4wa</span></p><p>Further company coverage: <span>RLYB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA47TQPH:1","article_id":"2616033717","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616033717","pubTimestamp":1772457843,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger AgreementMarch 2 (Reuters) - Rallybio Corp RLYB.O:RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENTRALLYBIO CORP","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","RLYB":"Rallybio Corp.","BK4139":"生物科技"},"translate_title":"简介-Rallybio Corporation和Candid Therapeutics宣布达成合并协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RLYB":0.9},"content_text":"BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger AgreementMarch 2 (Reuters) - Rallybio Corp RLYB.O:RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENTRALLYBIO CORP - OVER $505 MILLION FINANCING COMMITTED BY INVESTORSRALLYBIO CORP: COMBINED COMPANY'S CASH BALANCE AT CLOSING IS EXPECTED TO FUND OPERATIONS THROUGH 2030RALLYBIO CORP: PRE-TRANSACTION RALLYBIO EQUITYHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 3.65% OF COMBINED CORALLYBIO CORP - KEN SONG TO LEAD COMBINED COMPANY AS CEORALLYBIO CORP - PRO-FORMA CASH OF ABOUT $700 MILLION EXPECTED AT CLOSINGSource text: ID:nBw1f6M4waFurther company coverage: RLYB.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}